Form D · Biotechnology
TARGETED DIAGNOSTICS & THERAPEUTICS INC
Exton, PA · CIK 0001163155
Offering snapshot reported Feb 26, 2016 · SEC filing
- Reported sold
- $761K Offering amount: $3M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Feb 11, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2016 | Initial | $760,792 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-258213
Source: Form D, filed Feb 26, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vijay Aggarwal | Director |
| Harry A. Arena | Director, Executive |
| Christopher J. Pippett | Director, Executive |
| Scott A. Waldman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
728 Springdale Drive, P.O. Box 558
Exton, PA, 19341
Exton, PA, 19341